Tranexamic acid in paediatric cardiac surgery

Indian Journal of Medical Research

Volumn 118, Issue AUG., 2003, Pages 86-89

  Chauhan, Sandeep ^a   Bisoi, Akshay ^a   Modi, Rakesh ^a   Gharde, Parag ^a   Rajesh, M R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antifrinolytics; Blood loss; Cardiac surgery; Postoperative; Tranexamic acid

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; FENTANYL; FIBRIN; FIBRINOGEN; HEPARIN; ISOFLURANE; KETAMINE; MIDAZOLAM; OXYGEN; PANCURONIUM; PROTAMINE; TRANEXAMIC ACID; TRXAMIC;

AGE; ANESTHESIA INDUCTION; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BODY WEIGHT; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DEGRADATION KINETICS; DEMOGRAPHY; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; GENDER; HEART SURGERY; HEMATOCRIT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL DRAINAGE; THROMBOCYTE COUNT;

ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PEDIATRICS; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 0345170975     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Harstein G, Jansens M. Treatment of excessive mediastinal bleeding after cardiopulmonary bypass. Ann Thorac Surg 1996; 62 : 1951-4.
2. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76 : 1680-97.
3. Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdrick M, et al. Haemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985; 11 : 281-92.
4. McLure PD, Izsak J. The use of epsilon aminocaproic acid to reduce bleeding after cardiopulmonary bypass in children with congenital heart disease. Anesthesiology 1974; 40 : 64-8.
5. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anesth 1992; 39 : 353-65.
6. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29 : 236-61.
7. Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky I, Goldman SM et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thor Cardiovasc Surg 1990; 99 : 70-4.
8. Janssens M, Hartstein G, David JL. Reduction in requirements for allogenic blood products: Pharmacological methods. Ann Thorac Surg 1996; 62 : 1944-50.
9. Zonis Z, Sears M, Reichert C, Sett S, Allen C. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1996; 111 : 982-7.
10. Bick RL. Hemostasis defects associated with cardiac surgery, prosthetic devices and other extracorporeal circuits. Semin Thromb Hemost 1985; 11 : 249-80.
11. Kern FH, Morana MJ, Sears J, Hickey PR. Coagulation defects in neonates undergoing cardiopulmonary bypass. Ann Thorac Surg 1992; 54 : 541-6.
12. Gralnick HR. Epsilon-adminocaproic acid in preoperative correction of hemostatic defect in cyanotic congenital heart disease. Lancet 1970; i: 1204-5.
13. Vander Salm TJ, Ansell JE, Okike ON. The role of epsilon aminocaproic acid in reducing bleeding after cardiac surgery: A double blind randomized study. J Thorac Cardiovasc Surg 1988; 95 : 538-42.
14. Levin E, Wu J, Devine DV, Alexander J, Reichert C, Sett S, et al. Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000; 83 : 54-9.
15. Reid RW, Zimmerman AA, Lausen PC, Mayer JE, Gorlin JB, Burrows FA. The efficacy of tranexamic acid versus placebo in decreasing blood loss in paediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997; 84 : 990-6.
16. Horrow JC, Van Riper DF, Strong MD, Brodoky I, Parmet J. Hemostatic effects of tranexamic acid and desmopression during cardiac surgery. Circulation 1991; 84 : 2063-70.